Evaluation of the Genotoxicity of Piplartine, an Alkamide of Piper Tuberculatum, in Yeast and Mammalian V79 Cells
Overview
Authors
Affiliations
The genus Piper belongs to the Piperaceae family, and includes species of commercial and medicinal importance. Chemical studies on Piper species resulted in the isolation of several biologically active molecules, including alkaloid amides, such as piplartine. This molecule, isolated from Piper tuberculatum, has significant cytotoxic activity against tumor cell lines, and presents antifungal, anti-platelet aggregation, anxiolytic, and antidepressant effects. In order to understand the biological properties of piplartine, this study investigated the genotoxicity and the induction of apoptosis by piplartine in V79 cells and its mutagenic and recombinogenic potential in Saccharomyces cerevisiae. Piplartine induced dose-dependent cytotoxicity in S. cerevisiae cultures in either stationary -- or exponential growth phase. In addition, piplartine was not mutagenic when cells were treated during exponential-growth phase and kept in buffer solution, but it increased the frequencies of point, frameshift, and forward mutations when cells were treated in medium during growth. Piplartine treatment induced DNA strand breaks in V79 cells, as detected by neutral and alkaline comet assay. In cell cycle analysis, piplartine induced G2/M cell cycle arrest, probably as a consequence of the DNA damage induced and repair. Moreover, piplartine treatment induced apoptosis in a dose-dependent manner, as observed by a decrease in mitochondrial membrane potential and an increase in internucleosomal DNA fragmentation. These data suggest that the DNA damage caused by piplartine induces G2/M cell cycle arrest, followed by apoptosis. Moreover, we suggest that cells surviving piplartine-induced DNA damage can accumulate mutations, since this alkaloid was mutagenic and recombinogenic in S. cerevisiae assays.
Thermosensitive Polymeric Nanoparticles for Drug Co-Encapsulation and Breast Cancer Treatment.
Dartora V, Passos J, Costa-Lotufo L, Lopes L, Panitch A Pharmaceutics. 2024; 16(2).
PMID: 38399285 PMC: 10892816. DOI: 10.3390/pharmaceutics16020231.
Silva R, Machado T, da Fonseca A, Tejera E, Perez-Castillo Y, Robbs B Molecules. 2023; 28(4).
PMID: 36838660 PMC: 9964404. DOI: 10.3390/molecules28041675.
A Review of Bioactive Compounds and Antioxidant Activity Properties of Species.
Carsono N, Tumilaar S, Kurnia D, Latipudin D, Satari M Molecules. 2022; 27(19).
PMID: 36235309 PMC: 9573611. DOI: 10.3390/molecules27196774.
Identification of Novel Drug Candidate for Epithelial Ovarian Cancer Investigation and Validation.
Zou D, Bai J, Lu E, Yang C, Liu J, Wen Z Front Oncol. 2021; 11:745590.
PMID: 34745968 PMC: 8568458. DOI: 10.3389/fonc.2021.745590.
Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs.
Daley S, Cordell G Molecules. 2021; 26(13).
PMID: 34206470 PMC: 8270272. DOI: 10.3390/molecules26133800.